Männistö Ville, Färkkilä Martti, Pussinen Pirkko, Jula Antti, Männistö Satu, Lundqvist Annamari, Valsta Liisa, Salomaa Veikko, Perola Markus, Åberg Fredrik
Departments of Medicine, University of Eastern Finland and Kuopio University Hospital, Finland.
Department of Gastroenterology, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
JHEP Rep. 2019 Oct 23;1(5):345-352. doi: 10.1016/j.jhepr.2019.09.001. eCollection 2019 Nov.
BACKGROUND & AIMS: Gut-derived endotoxemia has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We analyzed whether endotoxemia is associated with incident advanced liver disease in the general population.
Serum lipopolysaccharide (LPS) was measured in 6,727 (3,455 male and 3,272 female, mean age 53.4 ± 10.9 years, mean body mass index 27.2 ± 4.5) individuals participating in the Finnish population-based health examination survey FINRISK 1997. Data were linked with electronic health registers for incident advanced liver disease (hospitalization, cancer or death related to liver disease). During a mean follow-up of 16.3 ± 3.8 years (109,282 person-years), 86 liver events occurred. Univariate and multivariate Cox regression, and Kaplan-Meier analyses were performed.
Serum LPS predicted incident advanced liver disease with a hazard ratio per 1 SD of 1.41 (95% CI 1.24-1.59; ≪0.001) when adjusted for age, sex, gamma-glutamyltransferase, metabolic syndrome, alcohol use, patatin-like phospholipase domain-containing protein 3 () I148M, waist-hip ratio and type 2 diabetes. This association remained robustly significant in additional multivariate analyses with various levels of adjustment. The association was accentuated among carriers of the risk variant. The population attributable fraction of the highest LPS tertile for liver events was 29.7%. However, LPS was not associated with all-cause mortality.
Serum LPS is associated with hospitalization, cancer or death related to liver disease in the general population, with the highest tertile potentially accounting for 30% of the risk of liver disease.
Lipopolysaccharide, a gut-derived bacterial endotoxin, has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We found that serum lipopolysaccharide levels were associated with incident advanced liver disease in the general population, with the highest tertile accounting for up to 30% of the risk of hospitalization, cancer or death related to liver disease.
肠道源性内毒素血症与慢性肝病的发生有关,但其在人群层面的相关性仍不明确。我们分析了内毒素血症是否与普通人群中晚期肝病的发生有关。
在参与1997年芬兰基于人群的健康检查调查FINRISK的6727名个体(3455名男性和3272名女性,平均年龄53.4±10.9岁,平均体重指数27.2±4.5)中测量血清脂多糖(LPS)。数据与晚期肝病(与肝病相关的住院、癌症或死亡)的电子健康记录相链接。在平均16.3±3.8年(109282人年)的随访期间,发生了86例肝脏事件。进行了单变量和多变量Cox回归分析以及Kaplan-Meier分析。
在调整了年龄、性别、γ-谷氨酰转移酶、代谢综合征、饮酒情况、含patatin样磷脂酶结构域蛋白3()I148M、腰臀比和2型糖尿病后,血清LPS每增加1个标准差,预测晚期肝病发生的风险比为1.41(95%可信区间1.24-1.59;≪0.001)。在各种调整水平的额外多变量分析中,这种关联仍然非常显著。在风险变异携带者中,这种关联更为明显。LPS最高三分位数对肝脏事件的人群归因分数为29.7%。然而,LPS与全因死亡率无关。
血清LPS与普通人群中与肝病相关的住院、癌症或死亡有关,最高三分位数可能占肝病风险的30%。
脂多糖是一种肠道源性细菌内毒素,与慢性肝病的发生有关,但其在人群层面的相关性仍不明确。我们发现,普通人群中血清脂多糖水平与晚期肝病的发生有关,最高三分位数占与肝病相关的住院、癌症或死亡风险的比例高达30%。